[Power of test in bioequivalence analysis. The comparison of tests in beagle dogs and humans].
D000328:Adult; D000818:Animals; D001682:Biological Availability; D002214:Capsules; D003495:Cyclandelate / Q000378:metabolism; D003975:Diazepam / Q000378:metabolism; D004285:Dogs; D005260:Female; D005439:Flufenamic Acid / Q000378:metabolism; D006118:Griseofulvin / Q000378:metabolism; D006801:Humans; D008297:Male; D009268:Nalidixic Acid / Q000378:metabolism; D013045:Species Specificity; D013607:Tablets; D013810:Therapeutic Equivalency
D002214:Capsules; D013607:Tablets; D006118:Griseofulvin; D009268:Nalidixic Acid; D003495:Cyclandelate; D005439:Flufenamic Acid; D003975:Diazepam